The Europe Ureteroscopy Market should witness market growth of 4.9% CAGR during the forecast period (2022-2028).
A tissue sample is taken during a biopsy and sent to a lab for additional analysis. Doctors frequently perform this operation when they suspect a tumor in any organ. If any malignant development is discovered in the kidneys or ureters, for instance, instruments are inserted through a ureteroscope to do a biopsy. A disorder called ureterovaginal fistula occurs when the ureters and vagina can communicate. Urinary incontinence is caused when urine from the ureters leaks into the vagina (urine leakage).
The most effective and preferable procedure for ureterovaginal fistula diagnosis is ureteroscopy. Although ureteroscopy is primarily a diagnostic procedure, kidney stones can also be removed using it as a less invasive treatment. A ureteroscopy used for therapeutic purposes involves the removal of stones using forceps or a small wire basket that is linked to the endoscope. No cuts or incisions are made at any point during the procedure.
Germany is the biggest market in Europe and among the biggest markets worldwide for medical technology. Foreign investors have some prospects to invest in this country due to the government's funding effort for health informatics and other initiatives, including the digitalization of healthcare. For instance, North Rhine-public Wesrphalia's hospitals have started to modernize their current buildings and re-organize their system. The regional government has a positive outlook on the adoption of novel medical technology and apparatus. The growing healthcare infrastructure and the expanding medical technology sector would support the regional market growth for ureteroscopy over the course of the projection period.
The Germany market dominated the Europe Ureteroscopy Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $76 Million by 2028. The UK market is anticipated to grow at a CAGR of 4.1% during (2022-2028). Additionally, The France market would exhibit a CAGR of 5.7% during (2022-2028).
Based on End-user, the market is segmented into Hospitals, Ambulatory Surgical Centers, and Others. Based on Product, the market is segmented into Flexible, and Semi- Rigid. Based on Application, the market is segmented Urolithiasis, Urinary Stricture, Kidney Cancer, and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Boston Scientific Corporation, Olympus Corporation, Hoya Corporation, Steris PLC, Stryker Corporation, Advin Health Care, Karl Storz SE & Co. KG, Richard Wolf GmbH, Cliniva Healthcare, and OTU Medical Inc.
A tissue sample is taken during a biopsy and sent to a lab for additional analysis. Doctors frequently perform this operation when they suspect a tumor in any organ. If any malignant development is discovered in the kidneys or ureters, for instance, instruments are inserted through a ureteroscope to do a biopsy. A disorder called ureterovaginal fistula occurs when the ureters and vagina can communicate. Urinary incontinence is caused when urine from the ureters leaks into the vagina (urine leakage).
The most effective and preferable procedure for ureterovaginal fistula diagnosis is ureteroscopy. Although ureteroscopy is primarily a diagnostic procedure, kidney stones can also be removed using it as a less invasive treatment. A ureteroscopy used for therapeutic purposes involves the removal of stones using forceps or a small wire basket that is linked to the endoscope. No cuts or incisions are made at any point during the procedure.
Germany is the biggest market in Europe and among the biggest markets worldwide for medical technology. Foreign investors have some prospects to invest in this country due to the government's funding effort for health informatics and other initiatives, including the digitalization of healthcare. For instance, North Rhine-public Wesrphalia's hospitals have started to modernize their current buildings and re-organize their system. The regional government has a positive outlook on the adoption of novel medical technology and apparatus. The growing healthcare infrastructure and the expanding medical technology sector would support the regional market growth for ureteroscopy over the course of the projection period.
The Germany market dominated the Europe Ureteroscopy Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $76 Million by 2028. The UK market is anticipated to grow at a CAGR of 4.1% during (2022-2028). Additionally, The France market would exhibit a CAGR of 5.7% during (2022-2028).
Based on End-user, the market is segmented into Hospitals, Ambulatory Surgical Centers, and Others. Based on Product, the market is segmented into Flexible, and Semi- Rigid. Based on Application, the market is segmented Urolithiasis, Urinary Stricture, Kidney Cancer, and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Boston Scientific Corporation, Olympus Corporation, Hoya Corporation, Steris PLC, Stryker Corporation, Advin Health Care, Karl Storz SE & Co. KG, Richard Wolf GmbH, Cliniva Healthcare, and OTU Medical Inc.
Scope of the Study
By End-user
- Hospitals
- Ambulatory Surgical Centers
- Others
By Product
- Flexible
- Semi- Rigid
By Application
- Urolithiasis
- Urinary Stricture
- Kidney Cancer
- Others
By Country
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
Key Market Players
List of Companies Profiled in the Report:
- Boston Scientific Corporation
- Olympus Corporation
- Hoya Corporation
- Steris PLC
- Stryker Corporation
- Advin Health Care
- Karl Storz SE & Co. KG
- Richard Wolf GmbH
- Cliniva Healthcare
- OTU Medical Inc.
Unique Offerings
- Exhaustive coverage
- The highest number of Market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Ureteroscopy Market, by End User
1.4.2 Europe Ureteroscopy Market, by Product
1.4.3 Europe Ureteroscopy Market, by Application
1.4.4 Europe Ureteroscopy Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market composition & scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Europe Ureteroscopy Market by End User
3.1 Europe Hospitals Market by Country
3.2 Europe Ambulatory Surgical Centers Market by Country
3.3 Europe Others Market by Country
Chapter 4. Europe Ureteroscopy Market by Product
4.1 Europe Flexible Market by Country
4.2 Europe Semi- Rigid Market by Country
Chapter 5. Europe Ureteroscopy Market by Application
5.1 Europe Urolithiasis Market by Country
5.2 Europe Urinary Stricture Market by Country
5.3 Europe Kidney Cancer Market by Country
5.4 Europe Others Market by Country
Chapter 6. Europe Ureteroscopy Market by Country
6.1 Germany Ureteroscopy Market
6.1.1 Germany Ureteroscopy Market by End User
6.1.2 Germany Ureteroscopy Market by Product
6.1.3 Germany Ureteroscopy Market by Application
6.2 UK Ureteroscopy Market
6.2.1 UK Ureteroscopy Market by End User
6.2.2 UK Ureteroscopy Market by Product
6.2.3 UK Ureteroscopy Market by Application
6.3 France Ureteroscopy Market
6.3.1 France Ureteroscopy Market by End User
6.3.2 France Ureteroscopy Market by Product
6.3.3 France Ureteroscopy Market by Application
6.4 Russia Ureteroscopy Market
6.4.1 Russia Ureteroscopy Market by End User
6.4.2 Russia Ureteroscopy Market by Product
6.4.3 Russia Ureteroscopy Market by Application
6.5 Spain Ureteroscopy Market
6.5.1 Spain Ureteroscopy Market by End User
6.5.2 Spain Ureteroscopy Market by Product
6.5.3 Spain Ureteroscopy Market by Application
6.6 Italy Ureteroscopy Market
6.6.1 Italy Ureteroscopy Market by End User
6.6.2 Italy Ureteroscopy Market by Product
6.6.3 Italy Ureteroscopy Market by Application
6.7 Rest of Europe Ureteroscopy Market
6.7.1 Rest of Europe Ureteroscopy Market by End User
6.7.2 Rest of Europe Ureteroscopy Market by Product
6.7.3 Rest of Europe Ureteroscopy Market by Application
Chapter 7. Company Profiles
7.1 Boston Scientific Corporation
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expense
7.1.5 Recent strategies and developments:
7.1.5.1 Product Launches and Product Expansions:
7.1.5.2 Acquisition and Mergers:
7.1.5.3 Approvals and Trials:
7.2 Olympus Corporation
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental and Regional Analysis
7.2.4 Recent strategies and developments:
7.2.4.1 Acquisition and Mergers:
7.3 Hoya Corporation
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Segmental and Regional Analysis
7.3.4 Research & Development Expenses
7.4 Steris PLC
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Segmental and Regional Analysis
7.4.4 Research & Development Expenses
7.5 Stryker Corporation
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Segmental and Regional Analysis
7.5.4 Research & Development Expense
7.6 Advin Health Care
7.6.1 Company Overview
7.7 Karl Storz SE & Co. KG
7.7.1 Company Overview
7.8 Richard Wolf GmbH
7.8.1 Company Overview
7.9 Cliniva Healthcare
7.9.1 Company Overview
7.10. OTU Medical, Inc.
7.10.1 Company Overview
Companies Mentioned
- Boston Scientific Corporation
- Olympus Corporation
- Hoya Corporation
- Steris PLC
- Stryker Corporation
- Advin Health Care
- Karl Storz SE & Co. KG
- Richard Wolf GmbH
- Cliniva Healthcare
- OTU Medical Inc.
Methodology
LOADING...
